Celsion is up 70% on their Phase 1b ovarian cancer drug in

Celsion is up 70% on their Phase 1b ovarian cancer drug in combo with chemotherapy & surgery.

https://www.smarteranalyst.com/2017/06/05/her...ket-today/

Don't sleep on K. I expect to see the cohort 1 data soon. It has been four months since it began.